Supernus Pharmaceuticals
SUPN
#4268
Rank
S$2.45 B
Marketcap
$44.05
Share price
0.77%
Change (1 day)
-2.63%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): S$0.12 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are S$0.66 Billion. , an increase over its 2023 earnings that were of S$6.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 S$0.13 B1787.92%
2023 S$6.97 M-92.36%
2022 S$91.24 M-29.8%
2021 S$0.12 B-49.79%
2020 S$0.25 B12.99%
2019 S$0.22 B7.58%
2018 S$0.21 B54.9%
2017 S$0.13 B84.25%
2016 S$74.62 M202.27%
2015 S$24.68 M-462.04%
2014 -S$6.82 Million-94%
2013 -S$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.29 Billion-316.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.12 B 1,516.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.06 B 12,856.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$11.28 Billion-8,661.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.43 B 7,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.46 B 17,721.60%๐Ÿ‡บ๐Ÿ‡ธ USA